ST7612AA1 is a novel potent and oral HDCA inhibitor that acts as an HIV-1 latency reactivator. ST7612AA1 showed significant antitumor activity at low concentrations in vitro and in vivo. ST7612AA1 has potential anticancer activity and can be used to study malaria.
Molekulargewicht:
405.51
Reinheit:
>99.99%
CAS Nummer:
[1428535-92-5]
Formel:
C20H27N3O4S
Target-Kategorie:
HIV Protease|||DNA/RNA Synthesis|||HDAC
T70692
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten